with nsaids reaching the gastric mucosa locally or via the blood circulation , the damage at therapeutic doses might be less with drugs having a weaker effect on gastric as compared to other types of cyclo-oxygenases , a short or moderate half-life , and strong anti-thromboxane/antileukotriene activity .
C0017136
gastric
C0038351
gastric